KP Tissue Inc. (TSE:KPT - Get Free Report) Director Sarah Astrea Kruger acquired 2,500 shares of the stock in a transaction dated Tuesday, August 27th. The stock was acquired at an average price of C$8.51 per share, for a total transaction of C$21,275.00.
KP Tissue Price Performance
KP Tissue stock traded down C$0.01 during midday trading on Wednesday, reaching C$8.43. The company's stock had a trading volume of 8,691 shares, compared to its average volume of 17,006. The stock has a market capitalization of C$84.05 million, a P/E ratio of 14.05, a PEG ratio of -0.88 and a beta of 0.37. The stock's 50-day simple moving average is C$8.49 and its 200-day simple moving average is C$8.45. KP Tissue Inc. has a 52-week low of C$8.02 and a 52-week high of C$10.48.
KP Tissue Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Monday, September 30th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.54%. The ex-dividend date of this dividend is Monday, September 30th. KP Tissue's dividend payout ratio (DPR) is 120.00%.
Analyst Upgrades and Downgrades
KPT has been the subject of a number of research reports. Desjardins lowered their target price on KP Tissue from C$11.00 to C$10.00 and set a "hold" rating for the company in a research report on Wednesday, May 15th. TD Securities upped their price objective on KP Tissue from C$8.50 to C$9.00 and gave the company a "hold" rating in a research report on Wednesday, August 14th.
View Our Latest Research Report on KP Tissue
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Recommended Stories
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.